Anumana, Inc. ™ is an innovative health technology company that combines artificial intelligence (AI) and translational science to decode electrocardiograms (ECGs) like never before. In collaboration with nference and Mayo Clinic Platform, Anumana harnesses cutting-edge AI to transform the ECG into a deep predictive tool and biomarker of diseases, enabling care providers to empower patients at an early stage.

Anumana is dedicated to improving patient care across the cardiac care continuum. Their AI solutions aim to unlock the electrical signals of the heart, enabling earlier and more accurate diagnosis, treatment, and interventions in cardiology. It's important to note that the AI solutions developed by Anumana are currently under investigation and have not yet received regulatory approval or clearance.

Led by a team of experienced professionals, including renowned medical experts from Mayo Clinic, Anumana strives to revolutionize the field of cardiology through their groundbreaking technology. To stay updated on their progress, follow Anumana on LinkedIn and Twitter. For those interested in learning more about Anumana, they offer a comprehensive one-pager featuring key corporate highlights and an overview of their technology.

Anumana is committed to privacy, adhering to strict privacy policies and terms of use. Join the Anumana team in their mission to redefine cardiac care and make a significant impact on patient outcomes. Explore their career opportunities and connect with this forward-thinking brand today